P2B-054

Curie Manavata Cancer Centre (Nashik, India) › P2B-054

P2B-054

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Phase II
Curie Manavata Cancer Centre (Nashik, India) · Dr. Nolan
consented 2012-11-27

completed

AEs

4

Serious

0

Dropout signal

–

Adverse events

4

Grade 1 asthenia with onset in cycle 3 (2013-01-31); assessed as not related to study drug (unlikely); not resolved at last follow-up.

mild assessed

Grade 1 blood alkaline phosphatase increased with onset in cycle 2 (2013-01-17); assessed as not related to study drug (unlikely); resolved 2013-02-16.

mild assessed

Grade 1 stomatitis with onset in cycle 1 (2012-12-12); assessed as related to study drug (probable); resolved 2012-12-19.

mild assessed

Grade 1 constipation with onset in cycle 1 (2012-12-09); assessed as not related to study drug (unlikely); resolved 2012-12-13.

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.